Table: Kissei Pharm -Q1 group results

Kissei Pharmaceutical

30/07/2024 07:00

Jul 30 (Reuters)- 
             Kissei Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2024        Jun 30, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             21.16               19.31            83.00    
                 (+9.6 pct)          (+18.6 pct)      (+9.8 pct)  
  Operating          2.16                1.63             4.20    
                 (+32.2 pct)                          (+4.6 pct)  
  Recurring          2.88                2.71             5.40    
                 (+6.0 pct)         (+236.2 pct)      (-12.1 pct) 
  Net                4.11                3.27            11.30    
                 (+25.8 pct)         (+99.6 pct)      (+1.2 pct)  
  EPS             92.89 yen           70.95 yen       255.62 yen  
  Ann Div                             82.00 yen        90.00 yen  
  -Q2 div                             41.00 yen        45.00 yen  
  -Q4 div                             41.00 yen        45.00 yen  
  
  NOTE - Kissei Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4547.T